bepotastine besilate ophthalmic solution (BBOS) 1.5%	placebo	ocular itching	21951	22253	For the PP population, the differences in mean ocular itching scores between the BBOS 1.5% and the placebo group were found to be statistically significant (P<0.001) at all visits and time points by the Wilcoxon rank-sum test and across all time points at a study visit by ANCOVA assessments (Table 3).
bepotastine besilate ophthalmic solution (BBOS) 1.5%	placebo	ocular itching	1207	1349	A statistically significant reduction in ocular itching was observed for BBOS 1.5% treatment compared to placebo at all time points (P<0.0001)
